Internal Medicine, Hematology · New York, NY
NPI
1467555342
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave
New York, NY, 10021
Phone (646) 227-3275
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
428 services
Medicare patients, 2024
78
Average age 70
Drug cost, 2024
$508K
386 prescriptions
Company payments, 2025
$30K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ann A Jakubowski was code 99215 (office e&m - established), 143 times for 37 patients. In total Ann A Jakubowski billed 428 services in 11 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 143 | 37 | $126.59 | $18K |
| 99214 Office E&M - Established | Office | 132 | 40 | $85.13 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 129 | 15 | $103.38 | $13K |
By year: 2022 $41K for 405 services; 2023 $48K for 477 services; 2024 $46K for 428 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ann A Jakubowski prescribed most often to Medicare patients was Acyclovir, with 98 prescriptions and refills. In total Ann A Jakubowski wrote 386 Medicare prescriptions that cost $508K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 98 | 154 | 25 | $4,637 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 37 | 50 | Under 11 | $159 |
| Tacrolimus Generic | 27 | 29 | Under 11 | $2,186 |
| Pantoprazole Sodium Generic | 24 | 36 | Under 11 | $98.03 |
| Prednisone Generic | 16 | 16 | Under 11 | $46.18 |
| Cresemba Isavuconazonium Sulfate | 14 | 14 | Under 11 | $100K |
| Ursodiol Generic | 13 | 19 | Under 11 | $1,816 |
| Prevymis Letermovir | 11 | 11 | Under 11 | $78K |
| Neupogen Filgrastim | 11 | 11 | Under 11 | $30K |
| Cyclosporine Modified Cyclosporine, Modified | 11 | 11 | Under 11 | $1,045 |
Brand drugs: - claims; generic drugs: 311 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ann A Jakubowski $30K ($30K in general payments such as food, travel and fees) from 2 companies. The largest payer was National Marrow Donor Program with $30K.
| Company | Payments | Amount |
|---|---|---|
| National Marrow Donor Program | 4 | $30K |
| Incyte Corporation INCY | 1 | $122 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.